KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $38.4 million.

  • West Pharmaceutical Services' Long-Term Deferred Tax rose 4769.23% to $38.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $38.4 million, marking a year-over-year increase of 4769.23%. This contributed to the annual value of $38.4 million for FY2025, which is 4769.23% up from last year.
  • Per West Pharmaceutical Services' latest filing, its Long-Term Deferred Tax stood at $38.4 million for Q4 2025, which was up 4769.23% from $27.9 million recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Long-Term Deferred Tax registered a high of $99.0 million during Q1 2023, and its lowest value of $17.3 million during Q3 2023.
  • For the 5-year period, West Pharmaceutical Services' Long-Term Deferred Tax averaged around $44.0 million, with its median value being $35.8 million (2024).
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first soared by 25874.44% in 2021, then tumbled by 7878.79% in 2024.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Long-Term Deferred Tax stood at $48.5 million in 2021, then skyrocketed by 35.26% to $65.6 million in 2022, then plummeted by 60.82% to $25.7 million in 2023, then rose by 1.17% to $26.0 million in 2024, then soared by 47.69% to $38.4 million in 2025.
  • Its last three reported values are $38.4 million in Q4 2025, $27.9 million for Q3 2025, and $29.7 million during Q2 2025.